By expenditures
| Name | Title | Type |
|---|---|---|
| Marija Norton | Controller | Auditee |
| Tracey Guidry Cooley | Managing Director | Auditee |
| Marija Jukic | INTERIM CONTROLLER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 400108 | 2025 | 2026-04-29 | DELOITTE & TOUCHE LLP | $147.08M |
| 351225 | 2024 | 2025-03-31 | Deloitte & Touche LLP | $245.01M |
| 304031 | 2023 | 2024-04-19 | Deloitte & Touche LLP | $208.64M |
| 35930 | 2022 | 2023-05-16 | Deloitte & Touche LLP | $199.34M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 400108 | 2025 | 2026-04-29 | 1210833 | 2025-004 | Material Weakness | Yes | EM |
| 400108 | 2025 | 2026-04-29 | 1210832 | 2025-004 | Material Weakness | Yes | EM |
| 400108 | 2025 | 2026-04-29 | 1210831 | 2025-004 | Material Weakness | Yes | EM |
| 400108 | 2025 | 2026-04-29 | 1210830 | 2025-002 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210829 | 2025-002 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210828 | 2025-002 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210827 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210826 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210825 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210824 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210823 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210822 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210821 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210820 | 2025-003 | Material Weakness | Yes | L |
| 400108 | 2025 | 2026-04-29 | 1210819 | 2025-004 | Material Weakness | Yes | EM |
| 400108 | 2025 | 2026-04-29 | 1210818 | 2025-004 | Material Weakness | Yes | EM |
| 400108 | 2025 | 2026-04-29 | 1210817 | 2025-004 | Material Weakness | Yes | EM |
| 35930 | 2022 | 2023-05-16 | 607972 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 607971 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 607970 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 607969 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 31530 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 31529 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 31528 | 2022-002 | Significant Deficiency | - | L |
| 35930 | 2022 | 2023-05-16 | 31527 | 2022-002 | Significant Deficiency | - | L |